Victor R. Vaz

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 356 citations · Full text

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Biagio Ricciuti, Kathryn C. Arbour, Amir Vajdi et al. · Journal of Thoracic Oncology · 2021 · 346 citations · Full text

Tumor Biology, Programmed Death-, Medicine +10

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti, Giuseppe Lamberti, Sreekar Reddy Puchala et al. · Journal of Clinical Oncology · 2024 · 100 citations · Full text

Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer

Joao V. Alessi, Biagio Ricciuti, Stephanie Alden et al. · Journal for ImmunoTherapy of Cancer · 2021 · 94 citations · Full text

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief et al. · Annals of Oncology · 2022 · 93 citations · Full text

Immunophenotypic Correlates, Oncology, Medicine +8